Sales exec indicted in DOJ’s generic pharma probe

A federal grand jury has indicted a former Taro Pharmaceuticals executive on charges of participating in two conspiracies to fix prices, rig bids and allocate customers for generic pharmaceuticals.

Get unlimited access to all Global Competition Review content